(Translated by https://www.hiragana.jp/)
Beatrice (psychedelic) - Wikipedia Jump to content

Beatrice (psychedelic)

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Beatrice
Names
Preferred IUPAC name
1-(2,5-Dimethoxy-4-methylphenyl)-N-methylpropan-2-amine
Other names
4-Methyl-2,5-dimethoxy-methamphetamine
2-(4-Methyl-2,5-dimethoxyphenyl)ethan-alpha,N-methylamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C13H21NO2/c1-9-6-13(16-5)11(7-10(2)14-3)8-12(9)15-4/h6,8,10,14H,7H2,1-5H3 checkY
    Key: IWYGVDBZCSCJGT-UHFFFAOYSA-N checkY
  • O(c1cc(c(OC)cc1CC(NC)C)C)C
Properties
C13H21NO2
Molar mass 223.316 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Beatrice (also known as MDO-D, MDOM, Béa and 4-methyl-2,5-dimethoxymethamphetamine) is a lesser-known psychedelic drug. It is a substituted methamphetamine and a homolog of 2,5-dimethoxy-4-methylamphetamine (DOM). Beatrice was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 30 mg, and the duration listed as 6–10 hours.[1] Beatrice produces a vague feeling of openness and receptiveness, and causes a stimulative effect. It also causes diarrhea. Very little data exists about the pharmacological properties, metabolism, and toxicity of beatrice.

In the US, this substance is a Schedule I isomer of DOET.

See also

References